ClinConnect ClinConnect Logo
Search / Trial NCT05635799

Virtual Reality Applied to the Evaluation and Rehabilitation of Locomotion - Study of Tolerance in the Lower Limb Amputee

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DIJON · Dec 1, 2022

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how virtual reality (VR) can help people with lower limb amputations improve their walking abilities. The researchers want to see if using VR can make rehabilitation exercises more effective by simulating real-life situations, such as walking on flat ground or going up and down slopes. By measuring how well both healthy volunteers and amputee patients adapt to these virtual scenarios, the study aims to find new ways to support rehabilitation and enhance mobility.

To participate, you must be an adult under 80 years of age, able to understand simple instructions, and either a healthy volunteer or someone with a unilateral lower limb amputation. The study involves three visits, where you'll perform walking tasks in different settings and share your experiences in a group discussion. This trial is currently recruiting participants at the Dijon Bourgogne University Hospital, and it aims to create a safer and more personalized approach to rehabilitation for lower limb amputees.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy volunteers:
  • Person who has given oral consent
  • Male or female over the age of majority, \< 80 years
  • Person able to understand simple commands, conditioning instructions
  • Amputee patients:
  • Person who has given oral consent
  • Male or female over the age of majority, \< 80 years
  • Patients with unilateral transfemoral or transtibial amputation of the lower limb of any origin (traumatic, vascular, congenital or neoplastic) with a definitive device.
  • Patients with stable locomotion with aids, without technical aids
  • Person able to understand simple orders, conditioning instructions
  • Exclusion Criteria:
  • Healthy Volunteers:
  • Person who is not affiliated or not a beneficiary of a social security system
  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a legal protection measure
  • Pregnant, parturient or breastfeeding woman
  • Major incapable or unable to express his consent
  • Minor
  • Person with locomotor disorders (orthopedic, neurological, vascular, cardiac...) and/or balance disorders that may significantly alter walking
  • Person with a contraindication to wearing a virtual reality helmet (uncontrolled epilepsy, wound of an area that the helmet would cover, severe ophthalmological disorders etc.)
  • Amputee patients:
  • Person who is not affiliated or not a beneficiary of a social security plan
  • Person under legal protection (guardianship, trusteeship)
  • Person subject to a legal protection measure
  • Pregnant, parturient or breastfeeding woman
  • Major incapable or unable to express his consent
  • Minor
  • Person with locomotor disorders (orthopedic, neurological, vascular, cardiac...) other than amputation that may significantly alter walking
  • Persons with contraindications to wearing a virtual reality helmet (uncontrolled epilepsy, wounds in an area that the helmet would cover, severe ophthalmological disorders, etc.)
  • Patients unable to participate in a group interview (qualitative study only)

About Centre Hospitalier Universitaire Dijon

The Centre Hospitalier Universitaire Dijon (CHU Dijon) is a leading academic medical institution in France, dedicated to advancing healthcare through innovative research and clinical trials. With a focus on patient-centered care, CHU Dijon integrates comprehensive medical services with cutting-edge research initiatives across various specialties. The institution is committed to enhancing clinical outcomes and improving health standards by facilitating rigorous scientific investigations and collaborations with national and international partners. By prioritizing ethical practices and adherence to regulatory standards, CHU Dijon aims to contribute significantly to the development of new therapies and medical technologies.

Locations

Dijon, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials